Cite
HARVARD Citation
Marabelle, A. et al. (n.d.). 807 A multicenter open-label phase I/lb study of SO-C101 as monotherapy and in combination with pembrolizumab in patients with selected advanced/metastatic solid tumors. Journal for immunotherapy of cancer. p. A483. [Online].